Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F0A4K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,356
Award facts
- Contract value 100% obligated
- $18,356.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,356.00 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count bottles). This firm fixed-price, non-set-aside contract was awarded on January 27, 2026, with an ultimate completion date of January 28, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Xeljanz XR is a prescription medication used primarily for rheumatoid arthritis and other inflammatory conditions, representing one of many pharmaceutical products AmerisourceBergen delivers through its federal contracts.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems globally. The parent company, Cencora, Inc., maintains an extended IDC with DLA valued at up to $999,999,999.00 through December 2031, demonstrating the company's significant role in sustaining the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F0A4K?
SPE2DR26F0A4K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F0A4K worth?
The government has obligated $18,356 on SPE2DR26F0A4K.
Is contract SPE2DR26F0A4K an order under another contract?
Yes. SPE2DR26F0A4K is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A4K competed?
The extent of competition for SPE2DR26F0A4K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award